Study Name: An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
12 locations found
- Pfizer Investigational Site
Location: Indianapolis, Indiana 46202
- Pfizer Investigational Site
Location: Indianopolis, Indiana 46290
- Pfizer Investigational Site
Location: Boston, Massachusetts 02114
- Pfizer Investigational Site
Location: Boston, Massachusetts 02115
- Pfizer Investigational Site
Location: Boston, Massachusetts 02215
- Pfizer Investigational Site
Location: Detroit, Michigan 48201
- Pfizer Investigational Site
Location: Farmington Hills, Michigan 48334
- Pfizer Investigational Site
Location: Cleveland, Ohio 44195
- Pfizer Investigational Site
Location: Seattle, Washington 98122
- Pfizer Investigational Site
Location: Seattle, Washington 98195
- Pfizer Investigational Site
Location: Seattle, Washington 98104
- Pfizer Investigational Site
Location: Seattle, Washington 98109
|